118 related articles for article (PubMed ID: 88972)
1. The effect of cultured endothelial cells on factor VIII procoagulant activity.
Stead NW; McKee PA
Blood; 1979 Sep; 54(3):560-72. PubMed ID: 88972
[TBL] [Abstract][Full Text] [Related]
2. Endothelial cell surface expression and binding of factor VIII/von Willebrand factor.
Jones TR; Kao KJ; Pizzo SV; Bigner DD
Am J Pathol; 1981 May; 103(2):304-8. PubMed ID: 6786103
[TBL] [Abstract][Full Text] [Related]
3. Some effects of calcium on the activation of human factor VIII/Von Willebrand factor protein by thrombin.
Switzer ME; McKee PA
J Clin Invest; 1977 Oct; 60(4):819-28. PubMed ID: 408379
[TBL] [Abstract][Full Text] [Related]
4. Immunologic studies of native and modified human factor VIII/von Willebrand factor.
Switzer ME; McKee PA
Blood; 1979 Aug; 54(2):310-21. PubMed ID: 88237
[TBL] [Abstract][Full Text] [Related]
5. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
[TBL] [Abstract][Full Text] [Related]
6. Binding and release of factor VIII/von Willebrand's factor by human endothelial cells.
Wall RT; Counts RB; Harker LA; Striker GE
Br J Haematol; 1980 Oct; 46(2):287-98. PubMed ID: 6775681
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells.
Hough C; Notley C; Mo A; Videl B; Lillicrap D
J Thromb Haemost; 2022 Nov; 20(11):2507-2518. PubMed ID: 35950488
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes.
Zelechowska MG; van Mourik JA; Brodniewicz-Proba T
Nature; 1985 Oct 24-30; 317(6039):729-30. PubMed ID: 3932886
[TBL] [Abstract][Full Text] [Related]
9. Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.
Houdijk WP; Sakariassen KS; Nievelstein PF; Sixma JJ
J Clin Invest; 1985 Feb; 75(2):531-40. PubMed ID: 3919060
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody to factor VIII that has less reactivity to factor VIII/von Willebrand factor complex.
Amano K; Arai M; Koshihara K; Suzuki T; Kagawa K; Nishida Y; Fukutake K
Am J Hematol; 1995 Aug; 49(4):310-7. PubMed ID: 7639276
[TBL] [Abstract][Full Text] [Related]
11. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
Saenko EL; Shima M; Gilbert GE; Scandella D
J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
[TBL] [Abstract][Full Text] [Related]
12. Agonist-stimulated release of von Willebrand factor and procoagulant factor VIII in rats with and without risk factors for stroke.
McCarron RM; Doron DA; Sirén AL; Feuerstein G; Heldman E; Pollard HB; Spatz M; Hallenbeck JM
Brain Res; 1994 Jun; 647(2):265-72. PubMed ID: 7922503
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models.
Denis CV; Kwack K; Saffaripour S; Maganti S; André P; Schaub RG; Wagner DD
Blood; 2001 Jan; 97(2):465-72. PubMed ID: 11154224
[TBL] [Abstract][Full Text] [Related]
14. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor.
Saenko EL; Scandella D
J Biol Chem; 1995 Jun; 270(23):13826-33. PubMed ID: 7775440
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII-East Hartford (arginine 1689 to cysteine) has procoagulant activity when separated from von Willebrand factor.
Aly AM; Hoyer LW
J Clin Invest; 1992 May; 89(5):1382-7. PubMed ID: 1569181
[TBL] [Abstract][Full Text] [Related]
16. Genetic induction of a releasable pool of factor VIII in human endothelial cells.
Rosenberg JB; Greengard JS; Montgomery RR
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2689-95. PubMed ID: 11116073
[TBL] [Abstract][Full Text] [Related]
17. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
[TBL] [Abstract][Full Text] [Related]
18. The endothelial lectin clearance receptor CLEC4M binds and internalizes factor VIII in a VWF-dependent and independent manner.
Swystun LL; Notley C; Georgescu I; Lai JD; Nesbitt K; James PD; Lillicrap D
J Thromb Haemost; 2019 Apr; 17(4):681-694. PubMed ID: 30740857
[TBL] [Abstract][Full Text] [Related]
19. Factor VIII von Willebrand factor antigen levels correlate with symptom severity in patients with Raynaud's phenomenon.
Lau CS; McLaren M; Belch JJ
Br J Rheumatol; 1991 Dec; 30(6):433-6. PubMed ID: 1747698
[TBL] [Abstract][Full Text] [Related]
20. Characterization of 25 monoclonal antibodies to factor VIII-von Willebrand factor: relationship between ristocetin-induced platelet aggregation and platelet adherence to subendothelium.
Stel HV; Sakariassen KS; Scholte BJ; Veerman EC; van der Kwast TH; de Groot PG; Sixma JJ; van Mourik JA
Blood; 1984 Jun; 63(6):1408-15. PubMed ID: 6426553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
